Spinocerebellar Ataxias Type 2 Completed Phase Trials for Dalfampridine (DB06637)
Also known as: Spinocerebellar Ataxia Type 2
| Indication | Status | Phase |
|---|---|---|
| DBCOND0062543 (Spinocerebellar Ataxias Type 2) | Completed | Not Available |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01811706 | Dalfampridine and Gait in Spinocerebellar Ataxias | Treatment |